A detailed history of Alliancebernstein L.P. transactions in Relay Therapeutics, Inc. stock. As of the latest transaction made, Alliancebernstein L.P. holds 138,281 shares of RLAY stock, worth $600,139. This represents 0.0% of its overall portfolio holdings.

Number of Shares
138,281
Previous 562,855 75.43%
Holding current value
$600,139
Previous $3.67 Million 73.32%
% of portfolio
0.0%
Previous 0.0%

Shares

17 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 14, 2024

SELL
$6.23 - $9.51 $2.65 Million - $4.04 Million
-424,574 Reduced 75.43%
138,281 $979,000
Q2 2024

Aug 14, 2024

BUY
$5.9 - $8.02 $143,086 - $194,501
24,252 Added 4.5%
562,855 $3.67 Million
Q1 2024

May 14, 2024

BUY
$7.5 - $12.07 $3 Million - $4.83 Million
400,322 Added 289.5%
538,603 $4.47 Million
Q4 2023

Feb 14, 2024

SELL
$6.01 - $11.48 $6.63 Million - $12.7 Million
-1,103,194 Reduced 88.86%
138,281 $1.52 Million
Q3 2023

Nov 14, 2023

SELL
$8.24 - $12.97 $5.19 Million - $8.17 Million
-629,555 Reduced 33.65%
1,241,475 $10.4 Million
Q2 2023

Aug 15, 2023

BUY
$9.99 - $18.27 $3.85 Million - $7.04 Million
385,116 Added 25.92%
1,871,030 $23.5 Million
Q1 2023

May 15, 2023

SELL
$15.0 - $22.76 $3.06 Million - $4.65 Million
-204,107 Reduced 12.08%
1,485,914 $24.5 Million
Q4 2022

Feb 14, 2023

BUY
$14.16 - $24.02 $4.06 Million - $6.88 Million
286,596 Added 20.42%
1,690,021 $25.2 Million
Q3 2022

Nov 15, 2022

SELL
$18.07 - $31.37 $8.49 Million - $14.7 Million
-469,839 Reduced 25.08%
1,403,425 $31.4 Million
Q2 2022

Aug 15, 2022

BUY
$13.31 - $34.88 $856,019 - $2.24 Million
64,314 Added 3.56%
1,873,264 $31.4 Million
Q1 2022

May 13, 2022

BUY
$20.26 - $32.36 $1.28 Million - $2.05 Million
63,323 Added 3.63%
1,808,950 $54.1 Million
Q4 2021

Feb 14, 2022

BUY
$26.0 - $37.03 $10.2 Million - $14.5 Million
391,364 Added 28.9%
1,745,627 $53.6 Million
Q3 2021

Nov 10, 2021

BUY
$29.75 - $37.99 $3.26 Million - $4.16 Million
109,498 Added 8.8%
1,354,263 $42.7 Million
Q2 2021

Jul 30, 2021

BUY
$27.5 - $38.19 $5.27 Million - $7.31 Million
191,474 Added 18.18%
1,244,765 $45.5 Million
Q1 2021

May 06, 2021

BUY
$32.52 - $61.53 $7.56 Million - $14.3 Million
232,522 Added 28.33%
1,053,291 $36.4 Million
Q4 2020

Feb 08, 2021

BUY
$35.51 - $54.03 $4.21 Million - $6.41 Million
118,608 Added 16.89%
820,769 $34.1 Million
Q3 2020

Nov 12, 2020

BUY
$32.81 - $45.1 $23 Million - $31.7 Million
702,161 New
702,161 $29.9 Million

Others Institutions Holding RLAY

About Relay Therapeutics, Inc.


  • Ticker RLAY
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 120,219,000
  • Market Cap $522M
  • Description
  • Relay Therapeutics, Inc. operates as a clinical-stage precision medicines company. It engages in transforming the drug discovery process with an initial focus on enhancing small molecule therapeutic discovery in targeted oncology and genetic disease indications. The company's lead product candidates include RLY-4008, an oral small molecule inhib...
More about RLAY
Track This Portfolio

Track Alliancebernstein L.P. Portfolio

Follow Alliancebernstein L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Alliancebernstein L.P., based on Form 13F filings with the SEC.

News

Stay updated on Alliancebernstein L.P. with notifications on news.